<!DOCTYPE html>
<html lang="en">

<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Lesson 24.6: Pharmacological Synergies & Contraindications for the Coach</title>
    <style>
        /* Base & Reset */
        * {
            box-sizing: border-box;
        }

        body {
            font-family: Georgia, 'Times New Roman', serif;
            line-height: 1.8;
            color: #2d2d2d;
            background: #f8f6f3;
            margin: 0;
            padding: 0;
        }

        /* Main Container */
        .lesson-container {
            max-width: 860px;
            margin: 0 auto;
            padding: 40px 30px;
            background: #ffffff;
            min-height: 100vh;
            box-shadow: 0 0 60px rgba(0, 0, 0, 0.08);
        }

        /* Brand Header */
        .brand-header {
            text-align: center;
            padding-bottom: 30px;
            margin-bottom: 35px;
            border-bottom: 1px solid #eee;
        }

        .brand-logo {
            max-width: 220px;
            height: auto;
            margin-bottom: 5px;
        }

        /* Module Header - BLUE/PURPLE theme for Master Practitioner */
        .module-header {
            background: linear-gradient(135deg, #1e3a8a 0%, #3b82f6 100%);
            padding: 35px 35px 30px;
            border-radius: 16px;
            margin-bottom: 30px;
            position: relative;
            overflow: hidden;
        }

        .module-header::before {
            content: '';
            position: absolute;
            top: 0;
            right: 0;
            width: 300px;
            height: 300px;
            background: radial-gradient(circle, rgba(255, 255, 255, 0.1) 0%, transparent 70%);
            transform: translate(100px, -100px);
        }

        .module-header::after {
            content: '';
            position: absolute;
            bottom: 0;
            left: 0;
            width: 100%;
            height: 4px;
            background: linear-gradient(90deg, #B8860B, #D4A84B, #B8860B);
        }

        .module-label {
            margin: 0;
            font-size: 11px;
            color: rgba(255, 255, 255, 0.75);
            text-transform: uppercase;
            letter-spacing: 2.5px;
            font-weight: 500;
        }

        .lesson-title {
            margin: 10px 0 0 0;
            font-size: 28px;
            color: #ffffff;
            font-weight: 700;
            line-height: 1.3;
            position: relative;
        }

        .lesson-meta {
            display: flex;
            gap: 12px;
            margin-top: 20px;
            padding-top: 18px;
            border-top: 1px solid rgba(255, 255, 255, 0.15);
            flex-wrap: wrap;
        }

        .meta-item {
            display: flex;
            align-items: center;
            gap: 6px;
            font-size: 12px;
            color: rgba(255, 255, 255, 0.85);
            background: rgba(255, 255, 255, 0.1);
            padding: 5px 12px;
            border-radius: 4px;
        }

        /* Table of Contents */
        .toc-box {
            background: linear-gradient(135deg, #fafafa 0%, #f5f5f5 100%);
            border-radius: 14px;
            padding: 24px 28px;
            margin-bottom: 35px;
            border: 1px solid #e8e8e8;
        }

        .toc-box .box-label {
            font-weight: 600;
            color: #1e3a8a;
            margin: 0 0 18px 0;
            font-size: 12px;
            text-transform: uppercase;
            letter-spacing: 2px;
            padding-bottom: 12px;
            border-bottom: 1px solid #e0e0e0;
        }

        .toc-list {
            list-style: none;
            margin: 0;
            padding: 0;
            display: grid;
            grid-template-columns: repeat(2, 1fr);
            gap: 8px 24px;
        }

        .toc-list li {
            margin: 0;
        }

        .toc-list a {
            display: flex;
            align-items: center;
            padding: 8px 12px;
            color: #555;
            text-decoration: none;
            font-size: 14px;
            border-radius: 6px;
            transition: all 0.2s ease;
        }

        .toc-list a:hover {
            background: white;
            color: #1e3a8a;
            box-shadow: 0 2px 8px rgba(0, 0, 0, 0.06);
        }

        .toc-list .section-num {
            display: inline-flex;
            align-items: center;
            justify-content: center;
            width: 26px;
            height: 26px;
            background: #1e3a8a;
            color: white;
            font-weight: 600;
            font-size: 11px;
            border-radius: 6px;
            margin-right: 12px;
            flex-shrink: 0;
        }

        /* Learning Objectives */
        .objectives-box {
            background: #eff6ff;
            border: 2px solid #3b82f6;
            border-radius: 14px;
            padding: 30px 35px;
            margin-bottom: 40px;
        }

        .objectives-box .box-label {
            font-weight: 600;
            color: #1e3a8a;
            margin: 0 0 18px 0;
            font-size: 13px;
            text-transform: uppercase;
            letter-spacing: 2px;
            display: flex;
            align-items: center;
            gap: 10px;
        }

        .objectives-box .box-label::before {
            content: 'ðŸŽ¯';
            font-size: 18px;
        }

        .objectives-box ul {
            margin: 0;
            padding-left: 22px;
        }

        .objectives-box li {
            margin-bottom: 14px;
            font-size: 16px;
            line-height: 1.7;
        }

        /* Key Terms Box */
        .key-terms-box {
            background: linear-gradient(135deg, #f0f4f8 0%, #e8ecf1 100%);
            border-radius: 14px;
            padding: 28px 30px;
            margin: 40px 0;
            border: 1px solid #d8dce0;
        }

        .key-terms-box .box-label {
            font-weight: 600;
            color: #1e3a8a;
            margin: 0 0 18px 0;
            font-size: 13px;
            text-transform: uppercase;
            letter-spacing: 2px;
        }

        .terms-grid {
            display: grid;
            grid-template-columns: repeat(auto-fit, minmax(280px, 1fr));
            gap: 16px;
        }

        .term-item {
            background: white;
            padding: 16px 18px;
            border-radius: 10px;
            border-left: 4px solid #3b82f6;
        }

        .term-item .term {
            font-weight: 700;
            color: #1e3a8a;
            font-size: 15px;
            margin: 0 0 6px 0;
        }

        .term-item .definition {
            font-size: 14px;
            color: #555;
            margin: 0;
            line-height: 1.6;
        }

        /* Section Headings */
        h2 {
            font-size: 24px;
            color: #1e3a8a;
            margin: 50px 0 20px 0;
            font-weight: 600;
            position: relative;
            padding-bottom: 12px;
        }

        h2::after {
            content: '';
            position: absolute;
            bottom: 0;
            left: 0;
            width: 60px;
            height: 3px;
            background: #B8860B;
        }

        h3 {
            font-size: 20px;
            color: #2563eb;
            margin: 30px 0 15px 0;
            font-weight: 600;
        }

        /* Paragraphs */
        p {
            font-size: 17px;
            margin-bottom: 20px;
            color: #333;
        }

        /* Highlights */
        .highlight {
            background: linear-gradient(180deg, transparent 60%, #FFF59D 60%);
            padding: 0 4px;
            font-weight: 500;
        }

        /* Alert Boxes */
        .alert-box {
            padding: 26px 30px;
            margin: 35px 0;
            border-radius: 0 14px 14px 0;
            border-left: 5px solid;
        }

        .alert-box .alert-label {
            font-weight: 600;
            margin: 0 0 12px 0;
            font-size: 12px;
            text-transform: uppercase;
            letter-spacing: 2px;
        }

        .alert-box.warning {
            background: #fff8e6;
            border-left-color: #ff9800;
        }

        .alert-box.warning .alert-label {
            color: #e65100;
        }

        .alert-box.info {
            background: #e3f2fd;
            border-left-color: #2196f3;
        }

        .alert-box.info .alert-label {
            color: #1565c0;
        }

        /* Case Study Box */
        .case-study {
            background: linear-gradient(135deg, #f8f9fb 0%, #f0f2f5 100%);
            border-radius: 16px;
            padding: 0;
            margin: 40px 0;
            overflow: hidden;
            box-shadow: 0 4px 20px rgba(0, 0, 0, 0.06);
        }

        .case-study-header {
            background: linear-gradient(135deg, #1e3a8a 0%, #3b82f6 100%);
            padding: 20px 30px;
            display: flex;
            align-items: center;
            gap: 15px;
        }

        .case-study-header .box-label {
            font-weight: 600;
            color: #ffffff;
            margin: 0;
            font-size: 16px;
        }

        .case-study-content {
            padding: 28px 30px;
        }

        .patient-profile {
            display: flex;
            align-items: center;
            gap: 18px;
            padding: 18px 22px;
            background: white;
            border-radius: 12px;
            margin-bottom: 20px;
            border: 1px solid #e5e5e5;
        }

        .patient-avatar {
            width: 55px;
            height: 55px;
            background: linear-gradient(135deg, #3b82f6, #1e3a8a);
            border-radius: 50%;
            display: flex;
            align-items: center;
            justify-content: center;
            font-size: 24px;
            flex-shrink: 0;
            color: white;
        }

        /* Statistics Highlight */
        .stat-highlight {
            font-weight: 700;
            color: #1e3a8a;
            font-size: 1.1em;
        }

        /* Data Table */
        .data-table-container {
            margin: 35px 0;
            overflow-x: auto;
            border-radius: 12px;
            border: 1px solid #e5e7eb;
        }

        table {
            width: 100%;
            border-collapse: collapse;
            font-size: 15px;
        }

        th {
            background: #f3f4f6;
            padding: 15px;
            text-align: left;
            font-weight: 600;
            color: #1e3a8a;
            border-bottom: 2px solid #e5e7eb;
        }

        td {
            padding: 15px;
            border-bottom: 1px solid #e5e7eb;
            vertical-align: top;
        }

        tr:last-child td {
            border-bottom: none;
        }

        /* Check Understanding Box */
        .check-understanding {
            background: linear-gradient(135deg, #fdfbf7 0%, #f9f5ed 100%);
            border: 2px solid #B8860B;
            border-radius: 16px;
            padding: 32px;
            margin: 45px 0;
        }

        .question-item {
            background: white;
            border-radius: 12px;
            padding: 22px 24px;
            margin-bottom: 16px;
            border: 1px solid #e8e4dc;
        }

        .reveal-btn {
            background: #1e3a8a;
            color: white;
            border: none;
            padding: 10px 20px;
            border-radius: 8px;
            font-size: 14px;
            cursor: pointer;
            transition: background 0.2s ease;
        }

        .answer-text {
            display: none;
            font-size: 14px;
            color: #1e40af;
            margin: 14px 0 0 0;
            padding: 14px;
            background: #eff6ff;
            border-radius: 8px;
        }

        /* Takeaways Box */
        .takeaways-box {
            background: linear-gradient(135deg, #f3f4f6 0%, #e5e7eb 100%);
            padding: 25px;
            margin-top: 35px;
            border-radius: 12px;
            border: 1px solid #d1d5db;
        }

        .takeaways-box .box-label {
            font-weight: 700;
            color: #1e3a8a;
            margin-bottom: 15px;
            text-transform: uppercase;
            font-size: 14px;
        }

        /* References Box */
        .references-box {
            margin-top: 50px;
            padding: 30px;
            background: #fafafa;
            border-radius: 12px;
            border: 1px solid #eee;
            font-size: 14px;
        }

        .references-box h4 {
            margin: 0 0 15px 0;
            color: #666;
            font-size: 16px;
        }

        .references-box ul {
            padding-left: 20px;
            color: #777;
        }

        .references-box li {
            margin-bottom: 8px;
        }

        /* Footer */
        .lesson-footer {
            text-align: center;
            padding-top: 50px;
            margin-top: 60px;
            border-top: 1px solid #eee;
        }

        .footer-logo {
            max-width: 140px;
            opacity: 0.8;
        }

        @media (max-width: 768px) {
            .toc-list { grid-template-columns: 1fr; }
            .lesson-container { padding: 20px 15px; }
        }
    </style>
</head>

<body>
    <div class="lesson-container">
        <div class="brand-header">
            <img src="/logoimg/LOGO_ACCREDI.png" alt="AccrediPro Academy" class="brand-logo">
        </div>

        <header class="module-header">
            <p class="module-label">Module 24: L3: Master Practitioner Skills</p>
            <h1 class="lesson-title">Lesson 6: Pharmacological Synergies & Contraindications for the Coach</h1>
            <div class="lesson-meta">
                <span class="meta-item">45 min read</span>
                <span class="meta-item">Lesson 6 of 8</span>
            </div>
        </header>

        <div class="toc-box">
            <p class="box-label">In This Lesson</p>
            <ul class="toc-list">
                <li><a href="#section1"><span class="section-num">1</span>The Master Coach's Pharmacological Scope</a></li>
                <li><a href="#section2"><span class="section-num">2</span>Non-Diabetic Glycemic Disruptors</a></li>
                <li><a href="#section3"><span class="section-num">3</span>Prescription-Nutrient Depletion Map</a></li>
                <li><a href="#section4"><span class="section-num">4</span>Iatrogenic Insulin Resistance</a></li>
                <li><a href="#section5"><span class="section-num">5</span>The S.T.A.B.L.E. Synergy Protocol</a></li>
                <li><a href="#section6"><span class="section-num">6</span>Facilitating the Deprescribing Dialogue</a></li>
            </ul>
        </div>

        <div class="objectives-box">
            <p class="box-label">Learning Objectives</p>
            <ul>
                <li>Identify common non-diabetic medications that induce secondary hyperglycemia.</li>
                <li>Master the "Prescription-Nutrient Depletion" map to optimize client micronutrient status.</li>
                <li>Recognize signs of over-medication as the S.T.A.B.L.E. Methodâ„¢ improves metabolic function.</li>
                <li>Differentiate between lifestyle-driven and drug-induced insulin resistance (iatrogenesis).</li>
                <li>Strategically guide clients through safe, physician-led deprescribing conversations.</li>
            </ul>
        </div>

        <h2 id="section1">1. The Master Coach's Pharmacological Scope</h2>
        <p>As a Master Practitioner, your role transcends basic lifestyle modifications. You must understand that your client exists in a complex <span class="highlight">biochemical environment</span> often dictated by polypharmacy. While we never prescribe or alter dosages, we must be the "first responders" to pharmacological interference that halts metabolic progress.</p>
        
        <p>A 2022 study published in <i>The Lancet</i> highlighted that the average Type 2 Diabetic patient is prescribed <span class="stat-highlight">6.4 concurrent medications</span>. Many of these medications, while treating primary symptoms like hypertension or inflammation, act as metabolic "handbrakes," making glycemic stability nearly impossible without practitioner intervention and physician collaboration.</p>

        <div class="alert-box info">
            <p class="alert-label">Master Practitioner Note</p>
            <p>Your goal is not to be a pharmacist, but to recognize when a client's "stubborn" blood sugar is actually a side effect of a prescription. This is the pinnacle of the <strong>S - Screen & Assess</strong> phase in the S.T.A.B.L.E. Methodâ„¢.</p>
        </div>

        <h2 id="section2">2. Non-Diabetic Glycemic Disruptors</h2>
        <p>Many clients enter coaching with "unexplained" spikes. Often, the culprit is not a hidden carbohydrate, but a non-diabetic medication. We categorize these as <span class="highlight">Iatrogenic Hyperglycemic Agents</span>.</p>

        <h3>Corticosteroids (Glucocorticoids)</h3>
        <p>Corticosteroids (e.g., Prednisone, Dexamethasone) are perhaps the most potent disruptors. They increase hepatic glucose production (gluconeogenesis) and decrease peripheral insulin sensitivity in muscle tissue. A meta-analysis found that <span class="stat-highlight">up to 46% of patients</span> without prior diabetes develop significant hyperglycemia when placed on high-dose glucocorticoids.</p>

        <h3>Beta-Blockers</h3>
        <p>Used for hypertension and anxiety, older beta-blockers (like Atenolol or Propranolol) can reduce insulin secretion and <span class="highlight">mask the symptoms of hypoglycemia</span> (tachycardia, tremors). This is a critical safety concern for coaches managing clients on insulin or sulfonylureas.</p>

        <h3>Statins (HMG-CoA Reductase Inhibitors)</h3>
        <p>While standard of care for cardiovascular risk, statins have a well-documented "diabetogenic" effect. Research indicates a <span class="stat-highlight">9% to 13% increased risk</span> of developing Type 2 Diabetes with long-term statin use, likely due to interference with GLUT4 translocation and pancreatic beta-cell calcium signaling.</p>

        <div class="data-table-container">
            <table>
                <thead>
                    <tr>
                        <th>Medication Class</th>
                        <th>Common Names</th>
                        <th>Glycemic Impact</th>
                        <th>Coaching Consideration</th>
                    </tr>
                </thead>
                <tbody>
                    <tr>
                        <td><strong>Corticosteroids</strong></td>
                        <td>Prednisone, Cortisone</td>
                        <td>Severe Elevation</td>
                        <td>Expect high fasting glucose; prioritize fiber matrix.</td>
                    </tr>
                    <tr>
                        <td><strong>Thiazide Diuretics</strong></td>
                        <td>HCTZ, Chlorthalidone</td>
                        <td>Mild/Moderate Elevation</td>
                        <td>Depletes Potassium/Magnesium; check electrolyte status.</td>
                    </tr>
                    <tr>
                        <td><strong>Statins</strong></td>
                        <td>Atorvastatin, Simvastatin</td>
                        <td>Mild Elevation / IR</td>
                        <td>Monitor HbA1c closely; supplement CoQ10 (with MD approval).</td>
                    </tr>
                    <tr>
                        <td><strong>Antipsychotics</strong></td>
                        <td>Quetiapine, Olanzapine</td>
                        <td>Moderate/Severe IR</td>
                        <td>Major weight gain risk; focus on satiety hormones (Leptin).</td>
                    </tr>
                </tbody>
            </table>
        </div>

        <h2 id="section3">3. Prescription-Nutrient Depletion Map</h2>
        <p>The "Drug-Nutrient Depletion" phenomenon is a critical blind spot in conventional care. Medications can interfere with the absorption, transport, storage, or excretion of essential metabolic micronutrients.</p>

        <div class="principle-card">
            <div class="principle-title">The "Big Three" Depletions</div>
            <div class="principle-text">
                <ul>
                    <li><strong>Metformin & B12:</strong> Long-term Metformin use is associated with a <span class="stat-highlight">30% reduction</span> in Vitamin B12 absorption. Deficiency mimics diabetic neuropathy, leading to misdiagnosis.</li>
                    <li><strong>Statins & CoQ10:</strong> Statins inhibit the mevalonate pathway, which produces both cholesterol and Coenzyme Q10. Low CoQ10 leads to mitochondrial dysfunction and muscle pain (myalgia).</li>
                    <li><strong>Diuretics & Magnesium:</strong> Loop and thiazide diuretics increase urinary excretion of Magnesium. Since Magnesium is a cofactor for over 300 enzymes (including the insulin receptor), this depletion worsens insulin resistance.</li>
                </ul>
            </div>
        </div>

        <div class="case-study">
            <div class="case-study-header">
                <div class="case-study-icon">ðŸ‘¤</div>
                <div>
                    <p class="box-label">Case Study: The "Neuropathy" Mystery</p>
                    <p class="subtitle">Metformin-Induced B12 Deficiency</p>
                </div>
            </div>
            <div class="case-study-content">
                <div class="patient-profile">
                    <div class="patient-avatar">D</div>
                    <div class="patient-info">
                        <h4>David, 62</h4>
                        <p>Type 2 Diabetic (10 years), Metformin (2000mg/day)</p>
                    </div>
                </div>
                <p><strong>Symptoms:</strong> David presented with increasing numbness and "pins and needles" in his feet. His doctor assumed it was progressing diabetic neuropathy despite his HbA1c being stable at 6.8%.</p>
                <p><strong>Intervention:</strong> As a Master Coach, the practitioner recognized the long-term Metformin use and suggested David ask his MD for a Serum B12 and Methylmalonic Acid (MMA) test. Results showed B12 at 180 pg/mL (Clinical Deficiency).</p>
                <p><strong>Outcome:</strong> After physician-prescribed B12 injections, David's "neuropathy" symptoms vanished within 4 weeks. His metabolic flexibility improved as B12 is crucial for the citric acid cycle.</p>
            </div>
        </div>

        <h2 id="section4">4. Iatrogenic Insulin Resistance</h2>
        <p>We must distinguish between <span class="highlight">metabolic insulin resistance</span> (caused by lifestyle) and <span class="highlight">iatrogenic insulin resistance</span> (caused by medical treatment). If a client is "doing everything right" according to the S.T.A.B.L.E. Methodâ„¢ but markers remain stagnant, we must look at the iatrogenic load.</p>
        
        <p>Iatrogenesis occurs when the treatment for one condition (e.g., inflammation) creates another (e.g., hyperglycemia). This creates a "prescribing cascade" where a client is given a second drug to treat the side effects of the first.</p>

        <div class="alert-box warning">
            <p class="alert-label">The Prescribing Cascade</p>
            <p>Example: Client takes <strong>Prednisone</strong> for RA -> Blood sugar rises -> MD prescribes <strong>Metformin</strong> -> Metformin depletes <strong>B12</strong> -> Client develops <strong>neuropathy</strong> -> MD prescribes <strong>Gabapentin</strong>. The coach's role is to identify the root (Prednisone) and work on lifestyle-based inflammation reduction to eventually allow for Prednisone reduction.</p>
        </div>

        <h2 id="section5">5. The S.T.A.B.L.E. Synergy Protocol</h2>
        <p>When medication and lifestyle coaching are synchronized, we achieve "Pharmacological Synergy." However, as the S.T.A.B.L.E. Methodâ„¢ improves insulin sensitivity, the client's current medication dosage may become <span class="highlight">toxic</span> or excessive.</p>

        <h3>Signs of Over-Medication (The "Healing Crisis")</h3>
        <p>As you implement <strong>A: Activate Movement</strong> and <strong>T: Transform Nutrition</strong>, keep a vigilant eye for these signs that the client's medication is now too strong for their improved physiology:</p>
        <ul>
            <li><strong>Recurrent Hypoglycemia:</strong> CGM data showing frequent "lows" after exercise or clean meals.</li>
            <li><strong>Orthostatic Hypotension:</strong> Dizziness when standing (common as blood pressure meds become too potent).</li>
            <li><strong>Excessive Bradycardia:</strong> Heart rate dropping too low (Beta-blocker synergy with improved fitness).</li>
            <li><strong>Unexplained Fatigue:</strong> Often a sign of excessive glucose lowering or nutrient depletion.</li>
        </ul>

        <h2 id="section6">6. Facilitating the Deprescribing Dialogue</h2>
        <p>The term <span class="highlight">Deprescribing</span> refers to the planned and supervised process of dose reduction or stopping of medication that might be causing harm or is no longer needed. <strong>Coaches do not deprescribe.</strong> We empower the client to lead the conversation with data.</p>

        <div class="principle-card">
            <div class="principle-title">The "Data-First" Physician Letter</div>
            <div class="principle-text">
                <p>Guide your client to present the following to their MD:</p>
                <ul>
                    <li><strong>CGM Reports:</strong> Show 14-day Time in Range (TIR) and hypoglycemic events.</li>
                    <li><strong>Symptom Journal:</strong> Log instances of dizziness, fatigue, or muscle pain.</li>
                    <li><strong>The Request:</strong> "Doctor, my blood sugar has stabilized significantly with my new lifestyle protocol. I am experiencing frequent lows. Can we review my dosages to see if a reduction is appropriate?"</li>
                </ul>
            </div>
        </div>

        <div class="check-understanding">
            <p class="box-label">Check Your Understanding</p>
            
            <div class="question-item">
                <p class="question-text">1. Which medication class is known to increase hepatic gluconeogenesis and can cause "steroid-induced diabetes"?</p>
                <button class="reveal-btn" onclick="this.nextElementSibling.classList.toggle('show')">Reveal Answer</button>
                <div class="answer-text">Corticosteroids (Glucocorticoids) like Prednisone are the primary culprits. They stimulate the liver to produce more glucose while making muscle cells more resistant to insulin.</div>
            </div>

            <div class="question-item">
                <p class="question-text">2. Why is Metformin-induced B12 deficiency particularly dangerous for a diabetic patient?</p>
                <button class="reveal-btn" onclick="this.nextElementSibling.classList.toggle('show')">Reveal Answer</button>
                <div class="answer-text">Because the symptoms of B12 deficiency (numbness, tingling, neuropathy) are identical to the symptoms of diabetic peripheral neuropathy. This often leads to the assumption that the diabetes is worsening, when in fact it is a vitamin deficiency.</div>
            </div>
        </div>

        <div class="takeaways-box">
            <p class="box-label">Key Takeaways</p>
            <ul>
                <li><strong>Screening is Continuous:</strong> Always check for new prescriptions; medications for unrelated issues (asthma, skin rashes, infections) can derail blood sugar.</li>
                <li><strong>Nutrient Depletion Matters:</strong> Supplementing what the drug "steals" (B12, CoQ10, Magnesium) can drastically improve client outcomes.</li>
                <li><strong>Safety First:</strong> Beta-blockers can mask hypoglycemia; coaches must rely on CGM data rather than subjective symptoms for these clients.</li>
                <li><strong>The Goal is Remission:</strong> Use the S.T.A.B.L.E. Methodâ„¢ to improve health so that the physician *wants* to deprescribe.</li>
            </ul>
        </div>

        <div class="references-box">
            <h4>References & Further Reading</h4>
            <ul>
                <li>Sattar, N., et al. (2010). "Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials." <i>The Lancet</i>.</li>
                <li>Hwang, J. L., & Weiss, R. E. (2014). "Steroid-induced diabetes: a clinical and molecular approach to understanding and treatment." <i>Diabetes/Metabolism Research and Reviews</i>.</li>
                <li>Aroda, V. R., et al. (2016). "Long-term Metformin Use and Vitamin B12 Deficiency in the Diabetes Prevention Program Outcomes Study." <i>Journal of Clinical Endocrinology & Metabolism</i>.</li>
                <li>Scott, I. A., et al. (2015). "Reducing Inappropriate Polypharmacy: The Process of Deprescribing." <i>JAMA Internal Medicine</i>.</li>
                <li>Morden, N. E., et al. (2021). "The Prescribing Cascade: A Strategy for Identification and Management." <i>Drugs & Aging</i>.</li>
            </ul>
        </div>

        <footer class="lesson-footer">
            <img src="/logoimg/LOGO_ACCREDI.png" alt="AccrediPro Academy" class="footer-logo">
            <p class="brand">AccrediPro Academy: Diabetes & Blood Sugar Coach Certification</p>
            <p class="copyright">&copy; 2024 AccrediPro Academy. All Rights Reserved. Professional Use Only.</p>
        </footer>
    </div>
</body>

</html>